Benitec Biopharma Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Raises Target Price to $20
Benitec Biopharma Participates in a Conference Call With Cantor Fitzgerald
Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market!
Suvretta Capital Purchases $11.7m in Benitec Biopharma Shares
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Promising Phase 1/2 Trial Results of BB-301 Support Buy Rating for Benitec Biopharma
Benitec Biopharma Reports Interim Results for 3 Subjects Treated With BB-301
Express News | Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated With Bb-301 in Phase 1B/2a Study to Be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
Benitec Biopharma to Participate in Upcoming Conferences in March
Benitec Biopharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Benitec Biopharma (BNTC) and Ardelyx (ARDX)
H.C. Wainwright Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $28
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $18
Analysts Are Bullish on These Healthcare Stocks: Benitec Biopharma (BNTC), Halozyme (HALO)